MTOR and chondrosarcoma: Based on these data and on studies showing additive effects of mTOR inhibitor with chemotherapy [14], [15], [18], [19], the antitumor effect of a combination of chemotherapy and/or everolimus, an mTOR inhibitor was tested in a preclinical rat chondrosarcoma model.